Chargement en cours...

Effect of beraprost on pulmonary hypertension due to left ventricular systolic dysfunction

Beraprost is used to treat peripheral chronic arterial occlusive disease. However, the efficacy and safety of beraprost in patients with pulmonary hypertension (PH) due to left ventricular systolic dysfunction (PH-HFrEF) remains unknown. The primary objective of this study was to determine the effec...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Medicine (Baltimore)
Auteurs principaux: Wang, Li, Zhu, Xinyi, Zhao, Liang-Ping, Wang, Maosong, Liu, Xiang, Chen, Yuqi, Chen, JianChang, Xu, WeiTing
Format: Artigo
Langue:Inglês
Publié: Wolters Kluwer Health 2019
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6494404/
https://ncbi.nlm.nih.gov/pubmed/31008926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000014965
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!